Back to Authors

Liu, Jianzhong

0000-0001-7826-7045

Mayo Clinic

AbbVie (United States)

Citations 3

S909 Efficacy of Upadacitinib in Patients With Crohn’s Disease Activity Index-Based Eligibility Criteria: Post Hoc Analysis of U-EXCEL, U-EXCEED, and U-ENDURE Phase 3 Trials
Lichtenstein, Gary R. , DuVall, Aaron, Chapman, J. Casey, Lacerda, Ana P. , Anyanwu, Samuel I., Garrison, Andrew, Dubinsky, Marla C. , Rubin, David T. , Loftus, Edward V. , Regueiro, Miguel , Anyanwu, Samuel, O’Brien, Daniel J. , Liu, Jianzhong

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S678-S679

10.14309/01.ajg.0000953276.85317.47 Get It

S0643 Composite and Individual Measures of Efficacy and Safety of Upadacitinib Treatment for Crohn's Disease: 12-Month Results From the Ongoing Phase 2 CELEST Open-Label Extension Study
D’Haens, Geert , Louis, Édouard , Lacerda, Ana P. , Panés, Julián , Louis, Edouard , Zhou, Qian , Liu, Jianzhong , Loftus, Edward V.

American Journal of Gastroenterology | October 24, 2020 | Volume: 115 | Issue: 1 | Pages: S322-S323

10.14309/01.ajg.0000704620.03018.6c Get It